Categories
MSU Bioethics on Facebook
Tweets
- From @NYTmag: How False Beliefs in Physical Racial Difference Still Live in Medicine Today ow.ly/FIZ830pmdh8 6 hours ago
- Watch: Pain But No Gain: Pain as a Problematic and Useless Concept? bioethics.msu.edu/brownbag-webin… 8 hours ago
- Our free archive of recorded #bioethics webinars contains lectures on a wide variety of topics from expert speakers: bioethics.msu.edu/brownbag-webin… 11 hours ago
- The 2019-2020 Bioethics Brownbag & Webinar Series will begin in October with the talk "Spinal Cord Injury: Everythi… twitter.com/i/web/status/1… 1 day ago
- From @PEHealthIT: Should Clinical Trials Account for Social Determinants of Health? ow.ly/WqJL30pmkcU 1 day ago
Top Posts & Pages
Archives
Meta
Tag Archives: cancer
Rights and Responsibilities at the End of Life
By Hannah Giunta, MPH, PhD
Questions about end-of-life care are always vexing, but a recent article in U.S. News and World Report suggests that cancer patients continue to receive useless but harmful treatments at the end of life (Thompson, 2016). A new research study presented at the American Society of Clinical Oncology’s (ASCO’s) annual meeting revealed that a big part of the problem comes from a lack of meaningful dialogue among physicians, patients, and family members. Continue reading
Patients’ Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer
Center Professor Emerita Dr. Margaret Holmes-Rovner is a contributing author on a new article published in Annals of Family Medicine, “Patients’ Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.” Published in the May/June 2016 issue, the study is … Continue reading
Posted in Articles, Publications, Uncategorized
Tagged Annals of Family Medicine, bioethics, cancer, cancer treatment, Margaret Holmes-Rovner, prostate cancer
Why not more research into preventing cancer?
This post is a part of our Bioethics in the News series. For more information, click here. By Tom Tomlinson, PhD Why are so much money and effort put into research aimed at curing cancer, and so little devoted to preventing … Continue reading
Posted in Bioethics in the News, Uncategorized
Tagged bioethics, cancer, drug development, drug trial, FDA, pharmaceutical industry, philosophy, research, Tom Tomlinson
8 Comments
Why can it be difficult for oncologists to refuse patients late chemotherapy?
Oncologists’ decisions about administering late chemotherapy: What makes it so difficult? Event Flyer Background: An estimated 20-50% of incurable cancer patients receive chemotherapy in the last 30 days of life, although little data support this practice. Few studies have explored … Continue reading
Posted in Brownbag & Webinar Series
Tagged cancer, chemotherapy, Minnie Bluhm, oncology, study, webinar
Precision Medicine/Ambiguous Ethics?
This post is a part of our Bioethics in the News series. For more information, click here. By Leonard Fleck, PhD In his State of the Union Address President Obama announced that he wished to set aside $215 million for his … Continue reading
Posted in Bioethics in the News
Tagged cancer, cancer treatment, genome, Imatinib, Leonard Fleck, precision medicine
11 Comments
The Joshua Hardy Case: Lessons Yet to Learn
This post is a part of our Bioethics in the News series. For more information, click here. By Hannah Giunta Earlier this month, major news outlets reported the story of 7-year-old Josh Hardy, a current end-stage cancer patient at St. Jude Children’s … Continue reading
